Best Stocks: News Corporation (NASDAQ:NWSA), Teladoc, Inc. (NYSE:TDOC), Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI), Protalix BioTherapeutics, Inc. (NYSEMKT:PLX), Northern Trust Corporation (NASDAQ:NTRS)

News Corp (NASDAQ:NWSA) on Wednesday reported fourth-quarter net loss to common stockholders of $379 million or $0.65 per share, compared with a profit of $12 million or $0.02 per share last year. News Corporation (NASDAQ:NWSA) belongs to Services sector. Its net profit margin is 2.80% and weekly performance is -3.29%. On last trading day company shares ended up $14.12. News Corporation (NASDAQ:NWSA) distance from 50-day simple moving average (SMA50) is -3.35%.

Teladoc, Inc. (NYSE:TDOC), the first and largest telehealth platform in the United States, reported a second quarter net loss available to stockholders of $17.06 million compared to a loss of $4.25 million, a year ago. Net loss per share was $7.20, compared to a loss of $2.15. Non-GAAP loss per share was $7.20, for the quarter. Teladoc, Inc. (NYSE:TDOC) shares fell -0.87% in last trading session and ended the day at $28.51. TDOC return on assets is -35.70%.
On Aug. 10, Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI), announced its second quarter results. The Company also disclosed its dermatological development program in which dermal formulations of its lead compound are being developed for common chronic skin disorders such as psoriasis, eczema (e.g., atopic dermatitis) and rare or orphan skin disorders. Patients and key opinion leaders agree there are unmet medical needs requiring new, safe and effective first-line treatments for dermatological diseases, and the Company believes the novel anti-inflammatory mechanism of action of its lead compound is well suited to meet these needs. The Company is directing its strategy to gain regulatory approval accordingly. Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI) shares fell -8.50% in last trading session and ended the day at $0.97. RCPI return on assets is -530.10%. Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI) quarterly performance is -52.69%.

Protalix BioTherapeutics Inc. (NYSEMKT:PLX) on Aug 10, reported a loss of $5.1 million in its second quarter. On a per-share basis, the Carmiel, Israel-based company said it had a loss of 5 cents. On 12 August, Protalix BioTherapeutics, Inc. (NYSEMKT:PLX) shares moved up 0.01% and was closed at $1.63. Protalix BioTherapeutics, Inc. (NYSEMKT:PLX) year to date (YTD) performance is -11.41%.

The City of Tallahassee has selected Northern Trust Corporation (NASDAQ:NTRS) to serve as global custodian for its $2.1 billion in assets. Northern Trust will also provide securities lending and performance reporting. Northern Trust will oversee assets for the city’s pension, other post-employment benefits and treasury portfolios. Northern Trust Corporation (NASDAQ:NTRS) ended the last trading day at $76.60. Company weekly volatility is calculated as 1.30% and price to cash ratio as 2.49. Northern Trust Corporation (NASDAQ:NTRS) showed a weekly performance of -0.79%.

Leave a Reply

Your email address will not be published. Required fields are marked *